Literature DB >> 18095013

Elderly onset systemic lupus erythematosus (SLE) presenting with disseminated intravascular coagulation (DIC).

Masayuki Iyoda1, Hiroki Suzuki, Eijin Ashikaga, Hisako Nagai, Aki Kuroki, Takanori Shibata, Kozo Kitazawa, Tadao Akizawa.   

Abstract

We describe an unusual case of elderly onset systemic lupus erythematosus (SLE) that presented with disseminated intravascular coagulation (DIC). An 86-year-old man who complained of general malaise was admitted for evaluation and treatment of thrombocytopenia. He was diagnosed as having SLE and DIC based on the criteria of the American College of Rheumatology for SLE (renal involvement, hematological abnormalities, and positivity for antinuclear antibody and lupus anticoagulant) and the criteria for DIC presented by the subcommittee on DIC of the ISTH (a large increase of fibrin degradation products [3 points] and a platelet count <50 x 10(3)/ml [2 points], resulting in a score of 5; a score > or =5 is compatible with DIC). The patient was treated with corticosteroid therapy (30 mg/day); the DIC and SLE remitted, and his renal function improved, but he developed pulmonary tuberculosis. Timely diagnosis, appropriate treatment, and an awareness of the potential for serious infections are of utmost importance when dealing with patients with elderly onset SLE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095013     DOI: 10.1007/s10067-007-0811-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  Human cytomegalovirus infection and systemic lupus erythematosus.

Authors:  J R Rider; W E Ollier; R J Lock; S T Brookes; D H Pamphilon
Journal:  Clin Exp Rheumatol       Date:  1997 Jul-Aug       Impact factor: 4.473

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  A case of elderly-onset systemic lupus erythematosus presenting as acute renal failure due to disseminated intravascular coagulation.

Authors:  M Iyoda; K Matsumoto; T Hato; A Kuroki; T Shibata; K Kitazawa; T Sugisaki
Journal:  Clin Nephrol       Date:  2005-10       Impact factor: 0.975

5.  Systemic lupus erythematosus associated with massive ascites and pleural effusion in a patient who presented with disseminated intravascular coagulation.

Authors:  Yo Kageyama; Takashi Yagi; Mamoru Miyairi
Journal:  Intern Med       Date:  2002-02       Impact factor: 1.271

6.  Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.

Authors:  R A Asherson; G Espinosa; R Cervera; J A Gómez-Puerta; J Musuruana; S Bucciarelli; M Ramos-Casals; A L Martínez-González; M Ingelmo; J C Reverter; J Font; D A Triplett
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

7.  Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index.

Authors:  F Formiga; I Moga; M Pac; F Mitjavila; A Rivera; R Pujol
Journal:  Lupus       Date:  1999       Impact factor: 2.911

Review 8.  Retroviruses and systemic lupus erythematosus.

Authors:  M Herrmann; M Hagenhofer; J R Kalden
Journal:  Immunol Rev       Date:  1996-08       Impact factor: 12.988

9.  Tuberculosis in patients with systemic lupus erythematosus.

Authors:  P H Feng; T H Tan
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

Review 10.  Disseminated intravascular coagulation in a patient with systemic lupus erythematosus with lupus anticoagulant.

Authors:  M Tanaka; S Kobayashi; N Tamura; H Hashimoto; S Hirose
Journal:  Intern Med       Date:  1993-06       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.